Clinical Trials Logo

Latent Tuberculosis clinical trials

View clinical trials related to Latent Tuberculosis.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT04988984 Enrolling by invitation - Clinical trials for Tuberculosis Infection

Development of Automated Molecular Diagnostic Platform for Tuberculosis Diagnosis (New Assay TB)

New Assay TB
Start date: November 17, 2020
Phase:
Study type: Observational

It is intended for patients who have been admitted to the outpatient or emergency room or are hospitalized For patients who diagnose pulmonary tuberculosis or extrapulmonary tuberculosis using Xpert TB/RIF, additionally, diagnose pulmonary tuberculosis or extrapulmonary tuberculosis using a new diagnostic method, and check the test results. Check whether the tuberculosis bacteria were actually cultured in the sample in the future, and compare the sensitivity and specificity in each test. Validation in animal model In an animal model (rat) with chronic obstructive pulmonary disease that shows similar characteristics to tuberculosis destructive lung, It will be investigated whether the HI method can be validated by separating and concentrating microbiome for various pathogens including Mycobacterium tuberculosis using HI method. Confirm.

NCT ID: NCT04443283 Enrolling by invitation - Infertility Clinical Trials

The Effect of Latent Tuberculosis Infection on the Pregnancy Outcome of IVF-ET

Start date: January 1, 2019
Phase:
Study type: Observational

This study evaluate the effect of latent infection of tuberculosis on the pregnancy outcome of IVF-ET in infertile patients with radiographic lesions suggesting old healed tuberculosis